...
首页> 外文期刊>Surgical Endoscopy >Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation.
【24h】

Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation.

机译:直肠内超声检查术前放化疗后在局部晚期直肠癌分期中的准确性。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The aim of our study was to determine the accuracy of endorectal ultrasonography (ERUS) in staging locally advanced rectal cancer after preoperative neoadjuvant chemoradiation and to point out the most common reasons for false interpretation. METHODS: Forty-four patients with locally advanced rectal cancer received neoadjuvant chemoradiation followed by radical surgery. Restaging was done 1-2 weeks before surgery and the results of ERUS staging were compared with histopathology findings of the resected specimen. RESULTS: The accuracy of ERUS for T stage after chemoradiation was 75% (33/44). Overstaging occurred in 18% (8/44) of patients, and 7% (3/44) were understaged. The majority of overstaging occurred in patients with ERUS T3 tumors, eventually found to have pathological pT0-pT2 staging. Five patients (11.4%) had complete histology regression and only one of these patients was staged correctly while others were overstaged. In the detection of perirectal lymph node metastases, ERUS was accuratein 68% of patients (30/44). Twenty percent (9/44) of patients were overstaged and 11% were (5/44) understaged. CONCLUSIONS: ERUS provides a good accuracy rate for staging rectal cancer after neoadjuvant chemoradiation. However, it is insufficient in detection of complete pathological response.
机译:目的:我们的研究目的是确定直肠内超声(ERUS)在术前新辅助化学放疗后分期局部晚期直肠癌的准确性,并指出错误解释的最常见原因。方法:44例局部晚期直肠癌患者接受了新辅助化学放疗,随后接受了根治性手术。在手术前1-2周进行再分期,将ERUS分期的结果与切除标本的组织病理学结果进行比较。结果:化学放疗后ERUS在T期的准确性为75%(33/44)。 18%(8/44)的患者过度分期,而7%(3/44)的患者分期不足。大多数过度分期发生在ERUS T3肿瘤患者中,最终发现具有病理性pT0-pT2分期。五名患者(占11.4%)已完全组织学消退,其中只有一名患者分期正确,而其他患者则分期过度。在直肠周围淋巴结转移的检测中,ERUS在68%的患者中准确无误(30/44)。百分之二十(9/44)的患者被过度治疗,百分之十一(5/44)的患者被过度治疗。结论:ERUS为新辅助放化疗后的直肠癌分期提供了良好的准确率。但是,它不足以检测出完整的病理反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号